Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023.
- Second-quarter revenue came in at $1.18 billion, up 1% from Q2 2022; a 3% increase on a constant currency basis
- Net loss per share was $1.48 in Q2, compared to a loss per share of $3.40 in the year-ago quarter
- On an adjusted basis, it was earnings of $0.32 per share for Q2 2023, compared to $0.57 per share last year
- The company expects fiscal year 2023 consolidated revenue growth of approximately 1%
- It is looking for a loss in the range of $2.08 per share to $1.93 per share for fiscal 2023
- Full-year adjusted earnings per share is expected to be in the range of $0.75 to $0.90
Most Popular
NKE Q2 Earnings Preview: Can Nike maintain the recovery momentum?
Sneaker giant NIKE, Inc. (NYSE: NKE) entered the fiscal year facing heightened competition and shifting consumer preferences. Its upcoming second-quarter results are expected to reflect these evolving industry dynamics and
Earnings Preview: Conagra Brands’ (CAG) sales and earnings projected to decline in Q2 2026
Shares of Conagra Brands, Inc. (NYSE: CAG) rose 1% on Friday. The stock has dropped 7% in the past three months. The branded food company is slated to report its
Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%
Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues
